Astraea

About

Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.

Founders

• 
  Sanmay Sarada· Founder

  prev Data Engineer @ Baylor College of Medicine | 4 Publications in Fetal Medicine | CS and Bio at Stanford

  LinkedIn ↗
• 
  Joshua Wang· Founder

  Previous undergraduate at Stanford studying CS and Math. Top 250 united states (USAMO) Qualifier, USACO Platinum, first intern at Salient (W23) developing enterprise systems.

  LinkedIn ↗

Product launches · 1 launch

• Astraea - Agents Accelerating clinical trials. ↗▲ 61May 14, 2026

  Astraea is an agentic platform that automates clinical trial data analysis and statistical programming, from raw study data to CDISC-compliant datasets, TFLs, and FDA-ready outputs.

Change history · 3 recorded

1. June 13, 2026
   • Pitch updated07:00 PM
2. June 9, 2026
   • Started hiring07:00 PM
3. May 14, 2026
   • New launch posted: Astraea - Agents Accelerating clinical trials.12:51 AM